文献速递牙周病

微创非手术治疗中度牙周骨内缺损辅助交联透明质酸:单盲随机对照临床试验

Non-Surgical Treatment of Moderate Periodontal Intrabony Defects With Adjunctive Cross-Linked Hyaluronic Acid: A Single-Blinded Randomized Controlled Clinical Trial.
PubMed 文献 · J Clin Periodontol · 2024-10-14

本研究纳入42例患者共42个邻间骨内缺损,随机分入微创非手术技术(MINST)联合交联透明质酸(xHyA)凝胶组或单纯MINST组。6个月时两组所有临床参数(除牙龈退缩外)均显著改善,但组间无显著差异;3个月时联合组在探诊深度和临床附着水平变化上显著优于对照组,6个月时联合组骨缺损填充变化显著优于对照组。

要点

  • MINST联合或不联合xHyA凝胶均可显著改善中度骨内缺损的临床参数。
  • xHyA凝胶辅助在3个月时对PD和CAL改善优于单纯MINST,但6个月时无显著差异。
  • 6个月时联合组影像学骨缺损填充变化显著优于单纯MINST组。

核心结论

  • MINST联合或不联合xHyA凝胶治疗骨内缺损在3个月和6个月时均使临床参数显著改善。
  • xHyA凝胶辅助MINST在3个月时改善临床结局优于单纯MINST,但6个月时未观察到统计学显著差异。

研究设计与样本

  • 单盲随机对照临床试验,42例患者共42个邻间骨内缺损随机分入试验组(MINST+xHyA)或对照组(单纯MINST)。

主要发现

  • 6个月时所有临床参数(除牙龈退缩外)均显著改善(p < 0.05),但组间无显著差异(p > 0.05)。
  • 3个月时试验组与对照组在PD和CAL变化上存在统计学显著差异(p < 0.05)。
  • 6个月时试验组与对照组骨缺损填充(DF)变化有统计学显著差异(p < 0.05)。
  • 6个月时两组影像学缺损角度(RDA)变化无统计学显著差异(p > 0.05)。

关键数值与推荐

  • 主要结局指标为探诊深度(PD)变化。
  • 在基线、3个月和6个月评估PD、CAL、GR和BOP;基线和6个月记录FMPS和FMBS。
  • 基线和6个月进行影像学评估,评估DF和RDA。

临床怎么用

  • MINST可作为中度牙周骨内缺损的非手术治疗选择。
  • 辅助xHyA凝胶可能在短期(3个月)改善PD和CAL,但6个月时临床差异不显著。
  • xHyA凝胶辅助可能有利于6个月时的影像学骨缺损填充。

局限性

  • 研究结论受限于其自身局限性(原文未具体说明)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To evaluate the clinical outcomes of moderate intrabony defects treated with minimally invasive non-surgical technique (MINST) with or without adjunctive delivery of cross-linked hyaluronic acid (xHyA) gel. MATERIALS AND METHODS: Forty-two patients with 42 interdental intrabony defects were randomly assigned to test (MINST + xHyA) or control procedures (MINST alone). Probing depth (PD), clinical attachment level (CAL), gingival recession (GR) and bleeding on probing (BOP) at the treated sites were assessed at baseline and at 3 and 6 months. Full-mouth plaque score (FMPS) and full-mouth bleeding score (FMBS) were recorded at baseline and after 6 months. Radiographic evaluation was performed at baseline and after 6 months, assessing the defect fill (DF) and radiographic defect angle (RDA). The primary outcome variable was PD change. RESULTS: Thirty-eight patients completed the trial without any adverse events. At 6 months, a statistically significant improvement (p < 0.05) was measured in all clinical parameters except GR (p > 0.05). However, no statistically significant differences were found between the experimental and control procedures (p > 0.05). Statistically significant differences between the test and control sites were observed at 3 months for PD and CAL changes (p < 0.05). The DF change was statistically significant when comparing experimental and control procedures at 6 months (p < 0.05). Both procedures failed to show statistically significant differences in terms of RDA changes at 6 months (p > 0.05). CONCLUSION: Within their limitations, the present results indicate that (a) treatment of intrabony defects with MINST, with or without application of xHyA gel, resulted in statistically significant improvements in the investigated clinical parameters at 3 and 6 months after therapy, and (b) although the adjunctive use of xHyA gel to MINST improved the clinical outcomes compared with MINST alone up to 3 months, statistically significant differences were not observed at 6 months. The study protocol was registered in ClinicalTrial.gov (NCT05188898).

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Iorio-Siciliano V, Blasi A, Mauriello L, et al. Non-Surgical Treatment of Moderate Periodontal Intrabony Defects With Adjunctive Cross-Linked Hyaluronic Acid: A Single-Blinded Randomized Controlled Clinical Trial. J Clin Periodontol. 2024. PMID: 39402910. doi:10.1111/jcpe.14078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。